Akèy › Leksemi limfoblastik egi › Tennessee › Memphis
Etid klinik pou Leksemi limfoblastik egi nan Memphis, TN
16 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Ap rekriteVolontè an sante akeyi
- St. Jude Children's Research Hospital, Memphis
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Ap rekriteFaz 1
- St. Jude Children's Research Hospital, Memphis
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Ap rekriteFaz 1
- St. Jude Children's Research Hospital, Memphis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Saint Jude Children's Research Hospital, Memphis
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Ap rekrite
- St. Jude Children's Research Hospital, Memphis
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Ap rekriteFaz 2
- St. Jude Children's Research Hospital, Memphis
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
Ap rekrite
- St. Jude Children's Research Hospital, Memphis
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Ap rekriteFaz 4
- St. Jude Children's Research Hospital, Memphis
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- St. Jude Childrens Research Hospital, Memphis
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Ap rekriteFaz 2
- St. Jude Children's Research Hospital, Memphis
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Ap rekriteFaz 1/2
- St. Jude Children's Research Hospital, Memphis
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
Ap rekriteFaz 1
- St. Jude Children's Research Hospital, Memphis
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
Ap rekriteFaz 2
- St. Jude Children's Research Hospital, Memphis
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
Ap rekriteFaz 1
- St. Jude Children's Research Hospital, Memphis
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Ap rekriteFaz 2
- St. Jude Children's Research Hospital, Memphis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- St. Jude Children's Research Hospital, Memphis
Etid Leksemi limfoblastik egi nan lòt vil
- Houston, TX28 etid
- New York City, NY24 etid
- Baldwin Park, CA21 etid
- Seattle, WA21 etid
- Chicago, IL19 etid
- Atlanta, GA19 etid
- Philadelphia, PA16 etid
- Washington, DC16 etid
- Boston, MA15 etid
- Los Angeles, CA14 etid
- Durham, NC13 etid
- Mountain View, CA13 etid
Lòt etid nan Memphis
- Kansè (tout kalite)31 etid
- Kansè Poumon ki pa ti selil23 etid
- Kansè nan tete22 etid
- Kansè poumon18 etid
- Maladi selil fòs18 etid
- Leksemi mieloïd egi15 etid
- Ensifizyans kadyak13 etid
- Kansè kolorektal11 etid
- Sarkom tisi mou11 etid
- Melanom11 etid
- Kansè pwostat11 etid
- Osteyosakòm10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.